Denise M. Adams, MD

Marjory J. Johnson Chair of Vascular Tumor Translational Research

Medical Director, Comprehensive Hemangioma and Vascular Malformation Center

Fellowship Director, Hematology / Oncology

Professor, UC Department of Pediatrics

Phone: 513-636-4266

Fax: 513-636-3549


Show All


Denise Adams, MD, is fellowship director of the Hematology / Oncology Fellowship Program and medical director of the Hemangioma and Vascular Malformations Center at Cincinnati Children’s. One of the vascular team’s main priorities has been establishing standards of care for patients with these diagnoses so they can follow outcome measures. Of key interest to Dr. Adams, as an oncologist, is the improvement in care of patients with kaposiform hemangioendotheliomas (KHE). The team of experts has established a clinical registry for these patients to gain insight into the clinical characteristics of KHE patients and the long term outcomes of these patients. They also have a phase II FDA funded trial for complicated vascular anomalies and KHE patients are included in this trial. These tumors are rare but have a very high mortality and morbidity rate. It is important that the group learn more about the clinical characteristics, phenotype, biomarkers which can lead to further investigations and clinical trials.

Education and Training

MD: Georgetown University School of Medicine, 1988.

Post-Graduate: Georgetown University, 1983.

BSN: Georgetown University, 1982.


View PubMed Publications


Phase II Study of Rapamycin for Complicated Vascular Anomalies. Food and Drug Administration. Sep 2009 - Aug 2013. #R01 FD 003712.